CABA (Cabaletta Bio) Total Assets: $148.15 Mil (As of Mar. 2026)


CABA Cabaletta Bio Inc CABA
34 GF Score
Price $3.03
! 1 Warning Sign
View Full Analysis

What is Cabaletta Bio Total Assets?

Cabaletta Bio CABA +3.75% 34 Total Assets is $148.15 Mil as of Mar. 2026. GuruFocus rates CABA with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Cabaletta Bio's Total Assets for the quarter that ended in Mar. 2026 was $148.15 Mil.

During the past 12 months, Cabaletta Bio's average Total Assets Growth Rate was 49.30% per year. During the past 3 years, the average Total Assets Growth Rate was 44.60% per year. During the past 5 years, the average Total Assets Growth Rate was 46.30% per year.

During the past 9 years, Cabaletta Bio's highest 3-Year average Total Assets Growth Rate was 72.40%. The lowest was 25.60%. And the median was 44.60%.

Total Assets is connected with ROA %. Cabaletta Bio's annualized ROA % for the quarter that ended in Mar. 2026 was -111.14%. Total Assets is also linked to Revenue through Asset Turnover. Cabaletta Bio's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Cabaletta Bio  (NAS:CABA) Total Assets Explanation

Total Assets is connected with ROA %.

Cabaletta Bio's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-174.06/( (165.083+148.146)/ 2 )
=-174.06/156.6145
=-111.14 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cabaletta Bio's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (165.083+148.146)/ 2 )
=0/156.6145
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cabaletta Bio Total Assets Related Terms

Cabaletta Bio Total Assets Historical Data

* Premium members only.

The historical data trend for Cabaletta Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabaletta Bio Total Assets Chart

Cabaletta Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only 126.34 116.97 253.65 185.05 165.08

Cabaletta Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 165.14 224.50 189.76 165.08 148.15
CABA
34GF Score
Cabaletta Bio Inc CABA
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabaletta Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cabaletta Bio's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=112.051+53.032
=165.08

Cabaletta Bio's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=103.305+44.841
=148.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $148.15 Mil mean?
Cabaletta Bio (CABA) has a Total Assets of $148.15 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Cabaletta Bio and its competitors.
Is Cabaletta Bio's Total Assets too high?
Cabaletta Bio's current Total Assets is $148.15 Mil. Overall, Cabaletta Bio has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cabaletta Bio's Total Assets compare to DNA and CADL?
Cabaletta Bio's Total Assets of $148.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cabaletta Bio and its competitors. Cabaletta Bio's current Total Assets is $148.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabaletta Bio stock overvalued right now?
Cabaletta Bio (CABA) has a current Total Assets of $148.15 Mil. The current Total Assets is $148.15 Mil. Cabaletta Bio's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cabaletta Bio (CABA), the current Total Assets is $148.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cabaletta Bio Business Description

Other Exchanges CABA:Mexico
Address 2929 Arch Street, Suite 600, Philadelphia, PA, USA, 19104
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
34GF Score

Get the complete analysis for CABA

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.03
Price